Dexcom Inc. Stock
Price
Target price
€265.70
€265.70
1.550%
4.05
1.550%
?
16:45 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
Dexcom Inc. gained 1.550% today.
The community is currently still undecided about Dexcom Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of €440.00 there is a hugely positive potential of 65.600% for Dexcom Inc. compared to the current price of €265.70.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 1.550% | -12.345% | -34.275% | -10.024% | -44.706% | 148.009% | 322.835% |
| Zimmer Holdings | -1.030% | 1.456% | -3.173% | -16.169% | -0.115% | 8.807% | 5.701% |
| Becton, Dickinson & Co. | 0.300% | -0.021% | -1.064% | 19.361% | 6.158% | 12.586% | 42.125% |
| Dentsply Sirona Inc. | 0.950% | 3.364% | -5.058% | -33.622% | -27.039% | -24.356% | -35.193% |
Comments
News
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on
Dexcom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.m. (Eastern Time). The